KINGSTON, N.Y., Jan. 27, 2026 /PRNewswire/ — Millrock Technology Inc (“Millrock”), a provider of freeze-drying and lyophilization solutions for the life sciencesKINGSTON, N.Y., Jan. 27, 2026 /PRNewswire/ — Millrock Technology Inc (“Millrock”), a provider of freeze-drying and lyophilization solutions for the life sciences

MILLROCK TECHNOLOGY APPOINTS TOM HOCHULI AS CEO

2026/01/28 02:33
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

KINGSTON, N.Y., Jan. 27, 2026 /PRNewswire/ — Millrock Technology Inc (“Millrock”), a provider of freeze-drying and lyophilization solutions for the life sciences and biopharmaceutical markets, announced today the appointment of Tom Hochuli as Chief Executive Officer. 

Mr. Hochuli brings more than three decades of executive leadership experience across life sciences, medical devices, and biologics manufacturing. He joins Millrock at a pivotal moment in the company’s journey and will play a key role in advancing Millrock’s vision to be the most trusted innovator of advanced lyophilization and processing technologies to pharmaceutical and biotech customers.

“Tom is a proven company builder with a deep understanding of complex manufacturing operations, team development, and mission-critical life sciences end markets,” said Bill Pezza, Executive Chairman for Millrock. “His track record of leading businesses makes him an ideal fit to lead Millrock’s next chapter. We are thrilled to welcome Tom to our leadership team”

Most recently, Mr. Hochuli served as President of a biologics-focused organization delivering cellular materials and end-to-end services to biotechnology and biopharmaceutical customers. In that role, he led a comprehensive operational and strategic transformation, improving financial performance, restructuring workflows, and positioning the organization for long-term sustainability. Earlier in his career, he successfully guided a private equity-backed life sciences manufacturing business through rapid operational scale and strategic exit.

Mr. Hochuli’s background spans senior leadership roles at both growth-oriented and global organizations, including responsibility for GMP manufacturing, supply chain, engineering, quality systems, and regulatory compliance.

“Millrock is a highly differentiated business with strong engineering capabilities, deep application expertise, and a reputation for quality that truly matters to its customers,” said Mr. Hochuli. “I’m excited to work alongside the Millrock team to build on that foundation—investing in people, technology, and operational excellence to support customers as they bring critical therapies to market.”

About Millrock Technology

Millrock Technology Inc. is an innovator of freeze-drying (lyophilization) instrumentation and process development solutions for the pharmaceutical, biotech, and diagnostics industries. Millrock specializes in laboratory, pilot, and production-scale lyophilizers, with advanced process control technologies designed to optimize efficiency, compliance, and scalability. To learn more, please visit www.millrocktech.com.

About Artemis

Headquartered in Boston, MA, Artemis is a specialized private equity firm focused on partnering with differentiated Industrial Tech companies, whose people and products enable a healthier, safer, more connected, and productive world. For more information on Artemis, please visit www.artemislp.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/millrock-technology-appoints-tom-hochuli-as-ceo-302671566.html

SOURCE Artemis

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

KAIO Global Debut

KAIO Global DebutKAIO Global Debut

Enjoy 0-fee KAIO trading and tap into the RWA boom